Elispot And Fluorospot Assays Market

Global ELISpot and FluoroSpot Assays Market, By Product (Assay Kits, Analyzers, Ancillary Products), By Application (Diagnostic Applications, Research Applications), By End-User (Hospitals & Clinics, Hospitals & Clinical Laboratories, Research Institutes, Biopharmaceutical Companies), By Region (North America, Europe, Asia-Pacific (APAC), Latin America (LATAM), Middle-East & Africa (MEA) Trend Analysis, Competitive Market Share & Forecast, 2017-2027

  • Published Date: August 2021
  • Report ID: BWC2117
  • Available Format: PDF
  • Page: 200

Report Overview

In the ELISpot and Fluorospot assay methods, the immune system can be studied at the single-cell level. In this technique, cells are cultured on microscopic plates coated with antibodies. Molecular components released by cells are blocked by antibodies. The approaches are frequently employed in the study of a variety of infectious diseases, as well as cancer research.

The global ELISpot and FluoroSpot assays market was worth USD 167.1 million in 2020 and is further projected to reach USD 605.4 million by the year 2027, growing at a CAGR of 20.6% during the forecast period. Increased incidence of chronic diseases, along with flu and other infectious diseases, as well as government initiatives focused on developing vaccines and monitoring viral infections are some of the factors driving the growth of the global ELISpot and FluoroSpot assays market.

Global ELISpot and FluoroSpot assays Market- Overview

In the ELISpot and Fluorospot assay methods, the immune system can be studied at the single-cell level. In this technique, cells are cultured on microscopic plates coated with antibodies. Molecular components released by cells are blocked by antibodies. The approaches are frequently employed in the study of a variety of infectious diseases, as well as cancer research.

ELISpot or enzyme-linked immune absorbent spot is a method of assessing the frequency of cytokines secretion for a single cell. Cytokines is a category of small proteins. ELISpot technique are increasingly being used in assessing adaptive and innate immune responses. FluoroSpot assays, on the other hand, is a technique which combines the property of ELISpot as well to study the secretion of more than one analyte at the same time. This assessing technique helps in study cells of varied behavior and functions but who are at the same cell level.

Global ELISpot and FluoroSpot assays Market Forecast and Trends

Growth Drivers

Rising Prevalence Various Infectious Diseases

Around thirty new diseases have emerged according to estimates given by the World Health Organization (WHO) over the last 20 years, which have now threatened the health of millions of people worldwide. Various infectious diseases, including HIV and COVID-19 are on the rise, making the development of effective treatments a crucial need.It has resulted in a huge demand for ELISpot and FluoroSpot assays because they demonstrate their efficiency in studying the behavior of diseases like HIV, small pox, hepatitis, tuberculosis, etc. This kind of assessment help in the development of vaccinations by studying the response of immune system. Because of this, the market of ELISpot and FluoroSpot assays are gaining significant traction over the past few years.

Expanding Research and Development Towards the Study Of Immune Responses

Because of the several advantages of the use of ELISpot and FluoroSpot assays in various purposes like study of Th1/Th2 responses, vaccine development, viral infection monitoring and treatment, autoimmune disease and transplantation, it has caught the attention of several investors. Government as well as private institutions are also funding research and development which includes the use of ELISpot and FluoroSpot assays. These assays are very helpful in detecting and tracking the response of immune system against pathogens. As a result, the demand for ELISpot and FluoroSpot is proliferating.

Restraints

Availability of Alternative Options

Despite the popularity and widespread usage of ELISpot and FluoroSpot, there are still a few variables that cause researchers to rely on its alternative options.This technique allows the tracking of only limited number of cell secretion. As a result, the chances of cell loss during the process gets very high. Furthermore, the availability of other options for detecting cell secretion like micro engraving, barcode chip, Total Internal Reflection Fluorescence Microscopy (TIRFM), etc.,is also one of the major factors hindering the market growth.

Impact of COVID-19 on Global ELISpot and FluoroSpot assays Market

Outreaching the expectations of experts and countries, the COVID-19 spread prove to be very intense, affecting the health of patients and developing serious conditions. Due to this, the need for intensive research arises for studying the virus and how humans can cope with it. This has resulted in the upsurge demand of the ELISpot and FluoroSpot assays. The demand was very prominent in the research laboratories and vaccine manufacturing companies as they were conducting several examination and tests for developing vaccines as soon as they can.

Global ELISpot and FluoroSpot assays Market - By Products

Based on products, the global ELISpot and FluoroSpot assays market is segmented into assay kits, analyzers, and ancillary products. The assay kits segment accounts for the largest market share. Assay kits have wide range of applicability. They are increasingly being used for viral infection monitoring and treatment, cancerology, vaccine development, etc. Therefore, the demand for assay kits is very high for both diagnostics and research purposes. They are very effective in assessing immune responses and measure the quality of the immune system cells.

Global ELISpot and FluoroSpot assays Market - By Application

Based on applications, the global ELISpot and FluoroSpot assays market is categorized into diagnostic applications and research applications. The diagnostic applications segment covers the major percentage of the market and is also projected to witness a high CAGR during the forecast period as well. The growth of the diagnostic segmentis driven by the development of advanced kits to detect disease early as well as the rising incidence of various infectious diseases.However, research applications segment is also gaining significant traction, especially after the outbreak COVID-19.

Global ELISpot and FluoroSpot Assays Market - By End-User

Based on end-user, the global ELISpot and FluoroSpot assays market is categorized into hospitals & clinics, research institutes, and biopharmaceutical companies. Since the outbreak of COVID-19 and other infectious diseases over the past few years, hospitals and clinics have accounted for the majority of the market share.However, ELISpot and FluoroSpot assays are also increasingly being used in research institutes, as research and development activities are in full swing from both the industry players and the government. Thus, the research institutes segment is likely to witness the fastest-growth during the forecast period.

Global ELISpot and FluoroSpot Assays Market - Regional Insights

Geographically, the global ELISpot and FluoroSpot assays market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle-East & Africa.  Among all the regions, North America dominates the market because of the expanding patient pool as well as developed healthcare infrastructure, which is pulling the demand for the ELISpot and FluoroSpot assays. Furthermore, high concentration of industry players in North America also makes it easy to access the kits and products, contributing to the market growth in this region. Europe's global position in the ELISpot and FluoroSpot industries has grown as a result of increased implementation of sophisticated products and the rise of manufacturers in the European countries. Additionally, mergers and acquisitions are also expanding the global presence of European markets.

Competitive Landscape

The leading market players in the global ELISpot and FluoroSpot assays market are Bio-Techne Corporation, Bio-Connect B.V., AutoimmunDiagnostika GmbH, Mabtech AB, U-Cytech Biosciences, Oxford Immunotec, Lophius Biosciences GmbH, Abcam, Cellular Technologies Limited, Becton, Dickinson and Company, Thermo Fisher Scientific, Elabscience, Biotech Investissement Group, Covance (LabCorp), and other prominent players.

Global players dominate the ELISpot and FluoroSpot assays market, covering a high percentage of the global market.In the industry, participants invest heavily in research and development to innovate and advance their products to offer early and accurate diagnosis of disease.Furthermore, the adoption of competitive strategies like partnerships, joint ventures, product approvals and launches is also very prominent in this market.

Recent Developments

  • In March 2021, Oxford Immunotec Global PLC announced the release of T-SPOT.COVID test. This test is a CE marked ELISpot based test for the detection of cell mediated (T cell) immune response to SARS-CoV-2 in human blood.
  • In December 2020, A joint research project involving Kobe University and Sysmex Corporation was launched to develop a test to detect T cells' immune response to Coronaviruses.

Scope of the Report

Attributes

Details

Years Considered

Historical data – 2017-2020

Base Year – 2020

Forecast – 2021 – 2027

Facts Covered

Revenue in USD Million

Market Coverage

North America, Europe, the Asia-Pacific, Latin America, and the Middle East and Africa

Product Service/Segmentation

By Product, By Application, By End-User, By Region

Key Players

Bio-Techne Corporation, Bio-Connect B.V., AutoimmunDiagnostika GmbH, Mabtech AB, U-Cytech Biosciences, Oxford Immunotec, Lophius Biosciences GmbH, Abcam, Cellular Technologies Limited, Becton, Dickinson and Company, Thermo Fisher Scientific, Elabscience, Biotech Investissement Group, Covance (LabCorp), and other prominent players.

 

By Product

  • Assay Kits
  • Analyzers
  • Ancillary Products

By Application

  • Diagnostic Applications

Infectious Diseases

Transplants

  • Research Applications

Vaccine Development

Clinical Trials

Cancer Research

By End-User

  • Hospitals & Clinics
  • Research Institutes
  • Biopharmaceutical Companies

By Region

  • North America
  • Europe
  • Asia-Pacific (APAC)
  • Latin America (LATAM)

Ø Middle-East & Africa (MEA)

FAQs:

1. What is the current size of the global ELISpot and FluoroSpot assays market?

Answer: The global ELISpot and FluoroSpot assays market reached USD 167.1 million in 2020.

2. What are the major factors driving the growth of the global ELISpot and FluoroSpot assays market?

Answer: The major factors driving the growth of the global ELISpot and FluoroSpot assays market are the rising prevalence various infectious diseases and expanding research and development towards the study of immune responses.

3. Who are the key players in the global ELISpot and FluoroSpot assays market?

Answer: The key players in the global ELISpot and FluoroSpot assays market are: Bio-Techne Corporation, Bio-Connect B.V., AutoimmunDiagnostika GmbH, Mabtech AB, U-Cytech Biosciences, Oxford Immunotec, Lophius Biosciences GmbH, Abcam, Cellular Technologies Limited, Becton, Dickinson and Company, Thermo Fisher Scientific, Elabscience, Biotech Investissement Group, Covance (LabCorp), and other prominent players.

4. Which end-user segment accounted for the largest share in the global ELISpot and FluoroSpot assays market?

Answer: The hospitals and clinics segment accounted for the largest share in the global ELISpot and FluoroSpot assays market.

5. Which region is at the highest growth rate in the global ELISpot and FluoroSpot assays market?

Answer: North America has the largest share in the global ELISpot and FluoroSpot assays market.